Susquehanna International Group’s Coya Therapeutics COYA Stock Holding History

Susquehanna International Group’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Buy	61,006 +21,690	+55%	+$100K	﹤0.01%	10668
2026 Q1	$155K	Sell	39,316 -85,515	-69%	-$400K	﹤0.01%	11963
2025 Q4	$724K	Buy	124,831 +91,476	+274%	+$556K	﹤0.01%	7949
2025 Q3	$190K	Sell	33,355 -16,795	-33%	-$102K	﹤0.01%	11048
2025 Q2	$288K	Sell	50,150 -8,832	-15%	-$51.2K	﹤0.01%	10430
2025 Q1	$382K	Buy	58,982 +28,247	+92%	+$179K	﹤0.01%	9513
2024 Q4	$176K	Buy	+30,735	New	+$209K	﹤0.01%	10865

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Susquehanna International Group's COYA Position: Q2 2026 in Review

Susquehanna International Group increased its Coya Therapeutics (COYA) stake by 55% in Q2 2026, buying an estimated $100K and bringing the position to 61,006 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #10668.

Susquehanna International Group first reported a position in COYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $724K in Q4 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

Susquehanna International Group held 61,006 shares of Coya Therapeutics worth $357K as of Q2 2026.
Susquehanna International Group bought 21,690 Coya Therapeutics shares in Q2 2026, an estimated $100K.
Coya Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #10668 holding.
Susquehanna International Group first reported a position in Coya Therapeutics in Q4 2024 and has held it in 7 quarters since.
Susquehanna International Group's Coya Therapeutics position peaked at $724K in Q4 2025.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.